John Culkin, director of information management, Crown Records Management, reveals why pharma companies should still prepare for the EU GDPR regardless of Brexit.
Pharmaceutical companies are being told to think twice before cancelling or delaying preparations for the forthcoming EU General Data Protection Regulation (GDPR), as the UK pushes ahead with Brexit.